95 related articles for article (PubMed ID: 21237254)
1. Abnormal expression of MAPK, EGFR, CK17 and TGk in the skin lesions of chloracne patients exposed to dioxins.
Liu J; Zhang CM; Coenraads PJ; Ji ZY; Chen X; Dong L; Ma XM; Han W; Tang NJ
Toxicol Lett; 2011 Mar; 201(3):230-4. PubMed ID: 21237254
[TBL] [Abstract][Full Text] [Related]
2. [Role of mitogen-activated protein kinase pathway in chloracne].
Zhang CM; Tang NJ; Dong L; Zhao LJ; Ma SW; Wei WG; Zhang WQ; Zhang P; Han W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Mar; 26(3):154-6. PubMed ID: 18761794
[TBL] [Abstract][Full Text] [Related]
3. Expression of AhR, CYP1A1, GSTA1, c-fos and TGF-alpha in skin lesions from dioxin-exposed humans with chloracne.
Tang NJ; Liu J; Coenraads PJ; Dong L; Zhao LJ; Ma SW; Chen X; Zhang CM; Ma XM; Wei WG; Zhang P; Bai ZP
Toxicol Lett; 2008 Apr; 177(3):182-7. PubMed ID: 18329192
[TBL] [Abstract][Full Text] [Related]
4. Chloracne: a case series on cutaneous expression of CYP1A1 as diagnostic biomarker.
Chessa MA; La Placa M; Patrizi A; Virdi A; Misciali C; Fedrizzi G; Filippi F; Saurat JH; Sorg O; Fontao F; Kaya G; Neri I
Clin Exp Dermatol; 2021 Jul; 46(5):896-900. PubMed ID: 33638914
[TBL] [Abstract][Full Text] [Related]
5. RASopathic comedone-like or cystic lesions induced by vemurafenib: a model of skin lesions similar but not identical to those induced by dioxins MADISH.
Kaya G; Saxer-Sekulic N; Kaya A; Sorg O; Boespflug A; Thomas L; Saurat JH
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1368-1372. PubMed ID: 29575357
[TBL] [Abstract][Full Text] [Related]
6. Toward elucidation of dioxin-mediated chloracne and Ah receptor functions.
Bock KW
Biochem Pharmacol; 2016 Jul; 112():1-5. PubMed ID: 26801687
[TBL] [Abstract][Full Text] [Related]
7. TCDD-induced activation of aryl hydrocarbon receptor regulates the skin stem cell population.
Mandavia C
Med Hypotheses; 2015 Mar; 84(3):204-8. PubMed ID: 25618441
[TBL] [Abstract][Full Text] [Related]
8. Chloracne: still cause for concern.
Passarini B; Infusino SD; Kasapi E
Dermatology; 2010 Aug; 221(1):63-70. PubMed ID: 20516651
[TBL] [Abstract][Full Text] [Related]
9. Blood lipid concentrations of dioxins and dibenzofurans causing chloracne.
Coenraads PJ; Olie K; Tang NJ
Br J Dermatol; 1999 Oct; 141(4):694-7. PubMed ID: 10583118
[TBL] [Abstract][Full Text] [Related]
10. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
11. Serum dioxin levels in former chlorophenol workers.
Collins JJ; Budinsky RA; Burns CJ; Lamparski LL; Carson ML; Martin GD; Wilken M
J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):76-84. PubMed ID: 16015278
[TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor Activation in Acne Vulgaris Skin: A Case Series from the Region of Naples, Italy.
Fabbrocini G; Kaya G; Caseiro Silverio P; De Vita V; Kaya A; Fontao F; Sorg O; Saurat JH
Dermatology; 2015; 231(4):334-8. PubMed ID: 26440531
[TBL] [Abstract][Full Text] [Related]
13. Dioxin-induced chloracne--reconstructing the cellular and molecular mechanisms of a classic environmental disease.
Panteleyev AA; Bickers DR
Exp Dermatol; 2006 Sep; 15(9):705-30. PubMed ID: 16881967
[TBL] [Abstract][Full Text] [Related]
14. [Chloracne after exposure to dioxin].
Pape F; Stahlmann R
Med Monatsschr Pharm; 2007 Jun; 30(6):206-12. PubMed ID: 17598702
[TBL] [Abstract][Full Text] [Related]
15. Human health effects: what the data indicate.
Gough M
Sci Total Environ; 1991 May; 104(1-2):129-58. PubMed ID: 1871586
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition.
Albanell J; Rojo F; Averbuch S; Feyereislova A; Mascaro JM; Herbst R; LoRusso P; Rischin D; Sauleda S; Gee J; Nicholson RI; Baselga J
J Clin Oncol; 2002 Jan; 20(1):110-24. PubMed ID: 11773160
[TBL] [Abstract][Full Text] [Related]
17. [Effects of dioxins on protein kinases and disruption of signal transduction pathways].
Aoki Y
Nihon Rinsho; 2000 Dec; 58(12):2458-63. PubMed ID: 11187737
[TBL] [Abstract][Full Text] [Related]
18. Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.
Chan KC; Knox WF; Gee JM; Morris J; Nicholson RI; Potten CS; Bundred NJ
Cancer Res; 2002 Jan; 62(1):122-8. PubMed ID: 11782368
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.
Malik SN; Siu LL; Rowinsky EK; deGraffenried L; Hammond LA; Rizzo J; Bacus S; Brattain MG; Kreisberg JI; Hidalgo M
Clin Cancer Res; 2003 Jul; 9(7):2478-86. PubMed ID: 12855621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]